Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 45, Issue 1, 2007, Pages 252-254

  Rigouts, Leen ^a   Nolasco, Oscar ^b   De Rijk, Pim ^a   Nduwamahoro, Elie ^a   Van Deun, Armand ^a   Ramsay, Andy ^d   Arevalo, Jorge ^b,c   Portaels, Françoise ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CODON; COLONY FORMING UNIT; GENE AMPLIFICATION; GENE MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RPOB GENE; SENSITIVITY AND SPECIFICITY; SPUTUM;

ANTIBIOTICS, ANTITUBERCULAR; BACTERIAL PROTEINS; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS COMPLEX;

EID: 33846248286     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01489-06     Document Type: Article

References (17)

1. Ahmad, S., and E. Mokaddas. 2005. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int. J. Antimicrob. Agents 26:205-212.
2. Bang, D., A. B. Andersen, and V. O. Thomsen. 2006. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J. Clin. Microbiol. 44:2605-2608.
3. Canetti, G., W. Fox, A. Khomenko, H. T. Mahler, N. K. Menon, D. A. Mitschison, N. Rist, and N. A. Smelev. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. W. H. O. 41:21-43.
4. De Beenhouwer, H., Z. Lhiang, G. Jannes, W. Mijs, L. Machtelinckx, R. Rossau, H. Traore, and F. Portaels. 1995. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber. Lung Dis. 76:425-430.
5. Gamboa, F., P. J. Cardona, J. M. Manterola, J. Lonea, L. Matas, E. Padilla, J. R. Monzano, and V. Auxina. 1998. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur. J. Clin. Microbiol. Infect. Dis. 17:189-192.
6. Heep, M., U. Rieger, D. Beck, and N. Lehn. 2000. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44:1075-1077.
7. Heep, M., B. Brandstätter, U. Rieger, N. Lehn, E. Richter, S. Rüsch-Gerdes, and S. Niemann. 2001. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39:107-110.
8. Hillemann, D., M. Weizenegger, T. Kubica, E. Richter, and S. Niemann. 2005. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 43:3699-3703.
9. Johansen, I. S., B. Lundgren, A. Sosnovskaja, and V. O. Thomsen. 2003. Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J. Clin. Microbiol. 41:4454-4456.
10. Makinen, J., H. J. Marttila, M. Marjamaki, M. K. Viljanen, and H. Soini. 2006. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 44:350-352.
11. Piersimoni, C., and C. Scarparo. 2003. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical specimens. J. Clin. Microbiol. 41:5355-5365.
12. Rossau, R., H. Traore, H. De Beenhouwer, W. Mijs, G. Jannes, P. De Rijk, and F. Portaels. 1997. Evaluation of the INNO-LIPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother. 41:2093-2098.
13. Senna, S. G., H. M. Gomes, M. O. Ribeiro, A. L. Kristki, M. L. Rossetti, and P. N. Suffys. 2006. In house reverse line hybridization assay for rapid detection of susceptibility to rifampicin in isolates of Mycobacterium tuberculosis. J. Microbiol. Methods 67:385-389.
14. Traore, H., K. Fissette, I. Bastian, M. Devleeschouwer, and F. Portaels. 2000. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int. J. Tuberc. Lung Dis. 4:481-484.
15. Traore, H., A. Van Deun, I. C. Shamputa, L. Rigouts, and F. Portaels. 2006. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J. Clin. Microbiol. 44:4384-4388.
16. Van Der Zanden, A. G., E. M. Te Koppele-Vije, N. Vijaya Bhanu, D. Van Soolingen, and L. M. Schouls. 2003. Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis. J. Clin. Microbiol. 41:1101-1108.
17. Watterson, S. A., S. M. Wilson, M. D. Yates, and F. A. Drobniewski. 1998. Comparison of three molecular assays for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 36:1969-1973.